Show simple item record

dc.contributor.authorDavies, Benjamin M
dc.contributor.authorYanez Touzet, Alvaro
dc.contributor.authorMowforth, Oliver D
dc.contributor.authorLee, Keng Siang
dc.contributor.authorKhan, Danyal
dc.contributor.authorFurlan, Julio C
dc.contributor.authorFehlings, Michael G
dc.contributor.authorHarrop, James S
dc.contributor.authorZipser, Carl Moritz
dc.contributor.authorRodrigues-Pinto, Ricardo
dc.contributor.authorMilligan, James
dc.contributor.authorSarewitz, Ellen
dc.contributor.authorCurt, Armin
dc.contributor.authorRahimi-Movaghar, Vafa
dc.contributor.authorAarabi, Bizhan
dc.contributor.authorBoerger, Timothy F
dc.contributor.authorTetreault, Lindsay
dc.contributor.authorChen, Robert
dc.contributor.authorGuest, James D
dc.contributor.authorKalsi-Ryan, Sukhvinder
dc.contributor.authorSadler, Iwan
dc.contributor.authorWiddop, Shirley
dc.contributor.authorMcNair, Angus G K
dc.contributor.authorKwon, Brian K
dc.contributor.authorKotter, Mark R N
dc.date.accessioned2022-06-13T13:44:00Z
dc.date.available2022-06-13T13:44:00Z
dc.date.issued2022-06-09
dc.identifier.urihttp://hdl.handle.net/10713/19127
dc.description.urihttps://doi.org/10.1136/bmjopen-2021-060436en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relationINTRODUCTION: Progress in degenerative cervical myelopathy (DCM) is hindered by inconsistent measurement and reporting. This impedes data aggregation and outcome comparison across studies. This limitation can be reversed by developing a core measurement set (CMS) for DCM research. Previously, the AO Spine Research Objectives and Common Data Elements for DCM (AO Spine RECODE-DCM) defined 'what' should be measured in DCM: the next step of this initiative is to determine 'how' to measure these features. This protocol outlines the steps necessary for the development of a CMS for DCM research and audit. METHODS AND ANALYSIS: The CMS will be developed in accordance with the guidance developed by the Core Outcome Measures in Effectiveness Trials and the Consensus-based Standards for the selection of health Measurement Instruments. The process involves five phases. In phase 1, the steering committee agreed on the constructs to be measured by sourcing consensus definitions from patients, professionals and the literature. In phases 2 and 3, systematic reviews were conducted to identify tools for each construct and aggregate their evidence. Constructs with and without tools were identified, and scoping reviews were conducted for constructs without tools. Evidence on measurement properties, as well as on timing of assessments, are currently being aggregated. These will be presented in phase 4: a consensus meeting where a multi-disciplinary panel of experts will select the instruments that will form the CMS. Following selection, guidance on the implementation of the CMS will be developed and disseminated (phase 5). A preliminary CMS review scheduled at 4 years from release.en_US
dc.relation.ispartofBMJ Openen_US
dc.rights© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.en_US
dc.subjectadult neurologyen_US
dc.subjectneurological injuryen_US
dc.subjectneurological painen_US
dc.subjectneurologyen_US
dc.subjectneuromuscular diseaseen_US
dc.subjectneurosurgeryen_US
dc.titleDevelopment of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS).en_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmjopen-2021-060436
dc.identifier.pmid35680260
dc.source.journaltitleBMJ open
dc.source.volume12
dc.source.issue6
dc.source.beginpagee060436
dc.source.endpage
dc.source.countryEngland


This item appears in the following Collection(s)

Show simple item record